| Product Code: ETC6349306 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Belgium continued to rely on imports of CIS insulin, with the top exporting countries being the USA, Austria, Netherlands, Hungary, and the UK. Despite a slight decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) for the period 2020-2024 remained impressive at 39.8%. The high Herfindahl-Hirschman Index (HHI) indicates a concentration of market power among the key exporting countries, highlighting the competitive dynamics in the CIS insulin import market in Belgium.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium CIS Insulin Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium CIS Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Belgium CIS Insulin Market - Industry Life Cycle |
3.4 Belgium CIS Insulin Market - Porter's Five Forces |
3.5 Belgium CIS Insulin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Belgium CIS Insulin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Belgium CIS Insulin Market Revenues & Volume Share, By Source, 2021 & 2031F |
4 Belgium CIS Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Belgium and CIS countries |
4.2.2 Growing awareness about the importance of insulin therapy for diabetes management |
4.2.3 Technological advancements in insulin delivery systems |
4.2.4 Rising healthcare expenditure in the region |
4.2.5 Government initiatives to improve diabetes care and access to insulin |
4.3 Market Restraints |
4.3.1 High cost associated with insulin therapy |
4.3.2 Stringent regulatory requirements for insulin products |
4.3.3 Limited access to healthcare services in some regions |
4.3.4 Competition from alternative diabetes management therapies |
4.3.5 Potential side effects and risks associated with insulin use |
5 Belgium CIS Insulin Market Trends |
6 Belgium CIS Insulin Market, By Types |
6.1 Belgium CIS Insulin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Belgium CIS Insulin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Belgium CIS Insulin Market Revenues & Volume, By Type I Diabetes, 2021- 2031F |
6.1.4 Belgium CIS Insulin Market Revenues & Volume, By Type II Diabetes, 2021- 2031F |
6.2 Belgium CIS Insulin Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Belgium CIS Insulin Market Revenues & Volume, By Rapid Acting, 2021- 2031F |
6.2.3 Belgium CIS Insulin Market Revenues & Volume, By Long Acting, 2021- 2031F |
6.2.4 Belgium CIS Insulin Market Revenues & Volume, By Short Acting, 2021- 2031F |
6.2.5 Belgium CIS Insulin Market Revenues & Volume, By Intermediate Acting, 2021- 2031F |
6.2.6 Belgium CIS Insulin Market Revenues & Volume, By Premixed, 2021- 2031F |
6.3 Belgium CIS Insulin Market, By Source |
6.3.1 Overview and Analysis |
6.3.2 Belgium CIS Insulin Market Revenues & Volume, By Analog, 2021- 2031F |
6.3.3 Belgium CIS Insulin Market Revenues & Volume, By Human Recombinant, 2021- 2031F |
7 Belgium CIS Insulin Market Import-Export Trade Statistics |
7.1 Belgium CIS Insulin Market Export to Major Countries |
7.2 Belgium CIS Insulin Market Imports from Major Countries |
8 Belgium CIS Insulin Market Key Performance Indicators |
8.1 Average time from diagnosis to initiation of insulin therapy |
8.2 Adoption rate of advanced insulin delivery systems |
8.3 Number of insulin prescriptions filled annually |
8.4 Patient adherence to insulin therapy regimen |
8.5 Percentage of healthcare facilities offering diabetes education programs |
9 Belgium CIS Insulin Market - Opportunity Assessment |
9.1 Belgium CIS Insulin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Belgium CIS Insulin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Belgium CIS Insulin Market Opportunity Assessment, By Source, 2021 & 2031F |
10 Belgium CIS Insulin Market - Competitive Landscape |
10.1 Belgium CIS Insulin Market Revenue Share, By Companies, 2024 |
10.2 Belgium CIS Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here